A recent CNN article discussed drugmaker Johnson & Johnson’s decision to pause their COVID-19 vaccine trial. The announcement came last Monday, and is attributed to an unexplained illness in one of the volunteers. The company is unclear whether the patient received a placebo or the experimental vaccine, but that’s not uncommon in a large scale study like this, which involves 60,000 patients.
Johnson & Johnson Pauses COVID-19 Vaccine Trial
The temporary pause is due to an “unexplained illness” in one participant.
Oct 19, 2020
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
